Company Monitoring Page for MannKind

latest headlines for company on cafepharma

MannKind And Afrezza's NDA Evaluation: What Is The Real Justification For The Advisory Committee?
Seeking Alpha
Fri, 03/28/14 - 08:21 am
Tags:
MannKind, diabetes, Afrezza, FDA, advisory panels
Does Mannkind Offer a Good Risk to Reward Ratio?
Motley Fool
Sat, 03/22/14 - 11:28 am
Tags:
MannKind
3 Biotechs With Major Catalysts Incoming
Motley Fool
Wed, 03/19/14 - 11:22 am
Tags:
dalbavancin, Durata Therapeutics, MannKind, Afrezza, Cologuard, EXACT Sciences
MLV Sees A Good Chance Of FDA Approval For MannKind's Afrezza And 60% Upside
Seeking Alpha
Tue, 03/18/14 - 12:14 pm
Tags:
FDA, MannKind, Afrezza, diabetes
MannKind: The Gambler's Creed - Let It Ride
Seeking Alpha
Fri, 03/14/14 - 10:54 am
Tags:
MannKind, Afrezza, diabetes
The 5 Most Hated Biotechs: Myriad, Sarepta, OncoMed, VIVUS, and MannKind
Motley Fool
Fri, 03/14/14 - 08:39 am
Tags:
biotech, Sarepta Therapeutics, OncoMed, Vivus, MannKind, Myriad Genetics
Biotech Stock Mailbag Extra: MannKind's Afrezza Panel Setup
TheStreet.com
Thu, 03/6/14 - 10:28 am
Tags:
advisory panels, FDA, Afrezza, diabetes, MannKind, inhaled insulin
5 Questions for MannKind
Motley Fool
Thu, 02/20/14 - 08:21 am
Tags:
MannKind, Afrezza, diabetes
The 5 Most Hated Biotechs: Myraid, Sarepta, Questcor, Ziopharm, and MannKind
Motley Fool
Wed, 02/19/14 - 08:44 am
Tags:
Myriad Genetics, Questcor, Ziopharm, Sarepta Therapeutics, MannKind
MannKind Corporation's CEO Discusses Q4 2013 Results - Earnings Call Transcript
Seeking Alpha
Wed, 02/19/14 - 08:37 am
Tags:
MannKind, earnings
Is There Investment Upside In The Future Of Treating Diabetes?
Seeking Alpha
Mon, 02/10/14 - 08:43 am
Tags:
diabetes, MannKind, Merck, Novo Nordisk, NeoStem, Regeneron
MannKind Catalysts: Insights About Diabetes Care Metrics And Long-Term Complications
Seeking Alpha
Thu, 01/23/14 - 08:19 am
Tags:
diabetes, MannKind, Afrezza
MannKind's Day Of Reckoning Is Getting Very Close
Seeking Alpha
Mon, 01/13/14 - 10:54 am
Tags:
MannKind, diabetes, Afrezza
2014 Biotechnology Catalysts
Seeking Alpha
Fri, 01/10/14 - 08:14 am
Tags:
Chelsea Therapeutics, Durect Corporation, EXACT Sciences, Vanda, Pozen, Progenics, MannKind, FDA
MannKind Corporation: One Large Step For Shareholders, One Gigantic Step For Diabetics
Seeking Alpha
Mon, 01/6/14 - 09:43 am
Tags:
MannKind, diabetes, Afrezza
More Catalysts For MannKind
Seeking Alpha
Fri, 12/6/13 - 11:12 am
Tags:
MannKind, Afrezza, diabetes, insulin
2014 FDA Drug Approval Decision Calendar
TheStreet.com
Wed, 11/27/13 - 08:39 am
Tags:
FDA, drug approvals, GSK, Gilead, Theravance, Auxilium, Amarin, Bristol-Myers Squibb, Biogen Idec, Pozen, Vanda, Chelsea Therapeutics, pSivida, Alimera, United Therapeutics, Biomarin, JNJ, Pharmacyclics, Celgene, MannKind, Santarus, AstraZeneca, Durata Therapeutics, Eli Lilly, Omeros, BioDelivery Sciences, Anacor, Keryx, Cubist Pharmaceuticals, Nektar
MannKind: A Breakout Biotechnology Bet
Seeking Alpha
Tue, 11/26/13 - 08:49 am
Tags:
MannKind, Afrezza, diabetes
Boom Or Bubble? Insiders Like The Look Of These 3 Biotech Stocks
The Street
Sat, 11/9/13 - 12:25 pm
Tags:
BioSpecifics Technologies, MannKind, Acadia
MannKind takes bigger 3Q loss as costs increase
Yahoo/AP
Mon, 11/4/13 - 03:15 pm
Tags:
MannKind, earnings

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.